Informações:
Falhas:
ID
34329
Descrição
Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection; ODM derived from: https://clinicaltrials.gov/show/NCT01147107
Link
https://clinicaltrials.gov/show/NCT01147107
Palavras-chave
Versões (1)
- 16/01/2019 16/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
16 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Hepatitis C, Chronic NCT01147107
Eligibility Hepatitis C, Chronic NCT01147107
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C, Chronic NCT01147107
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
hiv infected patients, age >18 years, meet vietnam guideline to begin art (cd4 count < 350 cells/mm3 and/or who stage iii or iv disease)
boolean
ID.2
Item
hepatitis c infection as documented by positive hcv antibodies and a detectable serum hcv rna level
boolean
ID.3
Item
ast and alt ≤ 2 x uln (≤ 80 u/l)
boolean
ID.4
Item
estimated creatinine clearance ≥ 60 ml/min
boolean
ID.5
Item
any prior art
boolean
ID.6
Item
positive hepatitis b surface antigen
boolean
ID.7
Item
clinical evidence of de-compensated cirrhosis (ascites, encephalopathy, esophageal bleeding)
boolean
ID.8
Item
requirement for acute therapy for other aids-defining illness within 14 days prior to study entry
boolean
ID.9
Item
currently on rifampicin therapy
boolean
ID.10
Item
in the first trimester of pregnancy, intent to become pregnant, or breast feeding during the study period
boolean